FCPM III SERVICES B.V. Long-Term Concentrated

CIK: 0002013410 · Show all filings

Period: Q1 2025 (← Previous) (Next →)

Filing Date: May 15, 2025

Total Value ($000): $413,711 (100.0% shares, 0.0% debt)

Holdings (7)

NAMS NEWAMSTERDAM PHARMA COMPANY 54.1%

Value ($000) $223,846 Shares 10,935,310 Est. Cost $9.56 Unrealized +132.4%

DYN DYNE THERAPEUTICS INC 13.8%

Value ($000) $57,141 Shares 5,462,846 Est. Cost $12.58 Unrealized +13.8%

ENGN ENGENE HOLDINGS INC 10.4%

Value ($000) $43,154 Shares 9,632,561 Est. Cost $10.14 Unrealized -38.7%

REPL REPLIMUNE GROUP INC 9.2%

Value ($000) $38,120 Shares 3,909,696 Est. Cost $11.59 Unrealized +6.7%

BCYC BICYCLE THERAPEUTICS PLC 7.1%

Value ($000) $29,310 Shares 3,452,330 Est. Cost $18.38 Unrealized —

— ASTRIA THERAPEUTICS INC 4.9%

Value ($000) $20,412 Shares 3,822,537 Est. Cost $8.05 Unrealized —

ENGNW ENGENE HOLDINGS INC 0.4%

Value ($000) $1,728 Shares 2,878,148 Est. Cost $0.63 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
NAMS	NEWAMSTERDAM PHARMA COMPANY	10,935,310	$223,846	54.1%	$9.56	+132.4%	ORDINARY SHARES	N62509109
DYN	DYNE THERAPEUTICS INC	5,462,846	$57,141	13.8%	$12.58	+13.8%	COM	26818M108
ENGN	ENGENE HOLDINGS INC	9,632,561	$43,154	10.4%	$10.14	-38.7%	COM	29286M105
REPL	REPLIMUNE GROUP INC	3,909,696	$38,120	9.2%	$11.59	+6.7%	COM	76029N106
BCYC	BICYCLE THERAPEUTICS PLC	3,452,330	$29,310	7.1%	$18.38	—	SPONSORED ADS	088786108
—	ASTRIA THERAPEUTICS INC	3,822,537	$20,412	4.9%	$8.05	—	COM	04635X102
ENGNW	ENGENE HOLDINGS INC	2,878,148	$1,728	0.4%	$0.63	—	W EXP 10/31/2028	29286M113